Linking an early access program (EAP) to the National Health Data System (NHDS) in France and assessing its performances and potential biases

Representatives of the Artificial Intelligence & Cancers Association, the French National Cancer Institute and AstraZeneca were honored to present at ASCO 2024 the results of a first collaborative project demonstrating the proof-of-concept of matching early access data with data from the SNDS.